Recent developments and current controversies in depression

Lancet

Volumn 367, Issue 9505, 2006, Pages 153-167

  Ebmeier, Klaus P ^a   Donaghey, Claire ^a   Steele, J Douglas ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; CATECHOLAMINE; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE MALEATE; MIRTAZAPINE; PAROXETINE; SEROTONIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRYPTOPHAN HYDROXYLASE; VENLAFAXINE;

BEHAVIOR THERAPY; BRAIN DEPTH STIMULATION; BRAIN FUNCTION; COGNITION; CONFERENCE PAPER; DEPRESSION; DNA POLYMORPHISM; DRUG COST; DRUG DEPENDENCE; DRUG MECHANISM; ELECTROCONVULSIVE THERAPY; HIPPOCAMPUS; HUMAN; MAINTENANCE INTERPERSONAL THERAPY; NEUROSURGERY; PATHOPHYSIOLOGY; PHARMACOGENETICS; PRESCRIPTION; PRIORITY JOURNAL; PROBLEM SOLVING; PSYCHOTHERAPY; SEIZURE; SUICIDE ATTEMPT; TRANSCRANIAL MAGNETIC STIMULATION; WITHDRAWAL SYNDROME;

EID: 30444450871     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)67964-6     Document Type: Conference Paper

References (195)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 4th edn. 1994 American Psychiatric Association Washington, DC
2. RC Kessler, P Berglund, O Demler The epidemiology of major depressive disorder: results from the national comorbidity survey replication (NCS-R) JAMA 289 2003 3095 3105
3. WHO The ICD-10 classification of mental and behavioural disorders: clinical description and diagnostic guidelines (CDDG) 1992 World Health Organization Geneva
4. J Spijker, R Graaf, RV Bijl, AT Beekman, J Ormel, WA Nolen Functional disability and depression in the general population. Results from the Netherlands mental health survey and incidence study (NEMESIS) Acta Psychiatr Scand 110 2004 208 214
5. J Ormel, AJ Oldehinkel, WA Nolen, W Vollebergh Psychosocial disability before, during, and after a major depressive episode: a 3-wave population-based study of state, scar, and trait effects Arch Gen Psychiatry 61 2004 387 392
6. J Hamalainen, E Isometsa, T Laukkala Use of health services for major depressive episode in Finland J Affect Disord 79 2004 105 112
7. I Aben, F Verhey, J Strik, R Lousberg, J Lodder, A Honig A comparative study into the one year cumulative incidence of depression after stroke and myocardial infarction J Neurol Neurosurg Psychiatry 74 2003 581 585
8. P Cuijpers, F Smit Excess mortality in depression: a meta-analysis of community studies J Affect Disord 72 2002 227 236
9. SB Guze, E Robins Suicide and primary affective disorders Br J Psychiatry 117 1970 437 438
10. FK Goodwin, KR Jamison Suicide FK Goodwin KR Jamison Manic-depressive illness 1990 Oxford University Press New York 227 244
11. JM Bostwick, VS Pankratz Affective disorders and suicide risk: a reexamination Am J Psychiatry 157 2000 1925 1932
12. PF Sullivan, MC Neale, KS Kendler Genetic epidemiology of major depression: review and meta-analysis Am J Psychiatry 157 2000 1552 1562
13. CJ Hong, SJ Tsai The genomic approaches to major depression Curr Pharmacogenom 1 2003 67 74
14. J Schumacher, RA Jamra, T Becker Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression Biol Psychiatry 58 2005 307 314
15. SJ Tsai, CY Cheng, YW Yu, TJ Chen, CJ Hong Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response Am J Med Genet B Neuropsychiatr Genet 123 2003 19 22
16. CJ Hong, SJ Huo, FC Yen, CL Tung, GM Pan, SJ Tsai Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior Neuropsychobiology 48 2003 186 189
17. TG Schulze, DJ Muller, H Krauss Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder Am J Med Genet 96 2000 801 803
18. L Du, D Bakish, A Ravindran, PD Hrdina MAO-A gene polymorphisms are associated with major depression and sleep disturbance in males Neuroreport 15 2004 2097 2101
19. A Szegedi, D Rujescu, A Tadic The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression Pharmacogenomics J 5 2005 49 53
20. JC Nelson Augmentation strategies in depression 2000 J Clin Psychiatry 61 suppl 2 2000 13 19
21. X Zhang, RR Gainetdinov, JM Beaulieu Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression Neuron 45 2005 11 16
22. A Caspi, K Sugden, TE Moffitt Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene Science 301 2003 386 389
23. NA Gillespie, JB Whitfield, B Williams, AC Heath, NG Martin The relationship between stressful life events, the serotonin transporter (5-HTTLPR) genotype and major depression Psychol Med 35 2005 101 111
24. KS Kendler, JW Kuhn, J Vittum, CA Prescott, B Riley The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication Arch Gen Psychiatry 62 2005 529 535
25. AR Hariri, VS Mattay, A Tessitore Serotonin transporter genetic variation and the response of the human amygdala Science 297 2002 400 403
26. AJ Fallgatter, MJ Herrmann, J Roemmler Allelic variation of serotonin transporter function modulates the brain electrical response for error processing Neuropsychopharmacology 29 2004 1506 1511
27. T Frodl, EM Meisenzahl, P Zill Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression Arch Gen Psychiatry 61 2004 177 183
28. WD Taylor, DC Steffens, ME Payne Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression Arch Gen Psychiatry 62 2005 537 544
29. J Kirchheiner, K Nickchen, M Bauer Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response Mol Psychiatry 9 2004 442 473
30. KM Smits, LJ Smits, JS Schouten, FF Stelma, P Nelemans, MH Prins Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review Mol Psychiatry 9 2004 433 441
31. JE Ilsley, AP Moffoot, RE O'Carroll An analysis of memory dysfunction in major depression J Affect Disord 35 1995 01 09
32. JA Sweeney, JA Kmiec, DJ Kupfer Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery Biol Psychiatry 48 2000 674 684
33. E Airaksinen, M Larsson, I Lundberg, Y Forsell Cognitive functions in depressive disorders: evidence from a population-based study Psychol Med 34 2004 83 91
34. YI Sheline, PW Wang, MH Gado, JG Csernansky, MW Vannier Hippocampal atrophy in recurrent major depression Proc Natl Acad Sci USA 93 1996 3908 3913
35. PJ Shah, KP Ebmeier, MF Glabus, GM Goodwin Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study Br J Psychiatry 172 1998 527 532
36. MP Austin, P Mitchell, GM Goodwin Cognitive deficits in depression: possible implications for functional neuropathology Br J Psychiatry 178 2001 200 206
37. P Fossati, PO Harvey, G Le Bastard, AM Ergis, R Jouvent, JF Allilaire Verbal memory performance of patients with a first depressive episode and patients with unipolar and bipolar recurrent depression J Psychiatr Res 38 2004 137 144
38. P Fossati, F Coyette, AM Ergis, JF Allilaire Influence of age and executive functioning on verbal memory of inpatients with depression J Affect Disord 68 2002 261 271
39. RJ Porter, P Gallagher, JM Thompson, AH Young Neurocognitive impairment in drug-free patients with major depressive disorder Br J Psychiatry 182 2003 214 220
40. PO Harvey, G Le Bastard, JB Pochon Executive functions and updating of the contents of working memory in unipolar depression J Psychiatr Res 38 2004 567 576
41. C Sobin, HA Sackeim Psychomotor symptoms of depression Am J Psychiatry 154 1997 04 17
42. MP Pier, W Hulstijn, BG Sabbe No psychomotor slowing in fine motor tasks in dysthymia J Affect Disord 83 2004 109 120
43. P Videbech, B Ravnkilde Hippocampal volume and depression: a meta-analysis of MRI studies Am J Psychiatry 161 2004 1957 1966
44. S Campbell, M Marriott, C Nahmias, GM MacQueen Lower hippocampal volume in patients suffering from depression: a meta-analysis Am J Psychiatry 161 2004 598 607
45. PJ Shah, MF Glabus, GM Goodwin, KP Ebmeier Chronic, treatment-resistant depression and right fronto-striatal atrophy Br J Psychiatry 180 2002 434 440
46. JD Bremner, P Randall, TM Scott MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder Am J Psychiatry 152 1995 973 981
47. JD Bremner, P Randall, E Vermetten Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse - a preliminary report Biol Psychiatry 41 1997 23 32
48. TV Gurvits, ME Shenton, H Hokama Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder Biol Psychiatry 40 1996 1091 1099
49. MB Stein, C Koverola, C Hanna, MG Torchia, B McClarty Hippocampal volume in women victimized by childhood sexual abuse Psychol Med 27 1997 951 959
50. S Campbell, G Macqueen The role of the hippocampus in the pathophysiology of major depression J Psychiatry Neurosci 29 2004 417 426
51. E Fuchs, B Czeh, MH Kole, T Michaelis, PJ Lucassen Alterations of neuroplasticity in depression: the hippocampus and beyond Eur Neuropsychopharmacol 14 suppl 5 2004 S481 S490
52. E Fuchs, B Czeh, G Flugge Examining novel concepts of the pathophysiology of depression in the chronic psychosocial stress paradigm in tree shrews Behav Pharmacol 15 2004 315 325
53. BS McEwen, S Chattarji Molecular mechanisms of neuroplasticity and pharmacological implications: the example of tianeptine Eur Neuropsychopharmacol 14 suppl 5 2004 S497 S502
54. RS Duman Depression: a case of neuronal life and death? Biol Psychiatry 56 2004 140 145
55. IC Reid, CA Stewart How antidepressants work: new perspectives on the pathophysiology of depressive disorder Br J Psychiatry 178 2001 299 303
56. LR Squire Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans Psychol Rev 99 1992 195 231
57. D Ebert, KP Ebmeier The role of the cingulate gyrus in depression: from functional anatomy to neurochemistry Biol Psychiatry 39 1996 1044 1050
58. WC Drevets Neuroimaging studies of mood disorders Biol Psychiatry 48 2000 813 829
59. HS Mayberg Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment RS Frackowiak T Jones Imaging neuroscience: clinical frontiers for diagnosis and management 2003 Oxford University Press Oxford 193 207
60. KP Ebmeier, D Kronhaus Brain imaging and mood disorders H D'haenen JA den Boer P Willner Biological psychiatry 2002 John Wiley and Sons London
61. JD Steele, SM Lawrie Neuroimaging EC Johnstone SM Lawrie Edinburgh companion to psychiatric studies 2004 Churchill Livingstone Edinburgh
62. ET Rolls The brain and emotion 1999 Oxford University Press Oxford
63. JD Steele, SM Lawrie Segregation of cognitive and emotional function in the prefrontal cortex: a stereotactic meta-analysis Neuroimage 21 2004 868 875
64. BA Vogt, DM Finch, CR Olson Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions Cereb Cortex 2 1992 435 443
65. JM Fuster The prefrontal cortex 1997 Lippincott-Raven New York
66. WC Drevets Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression HBM Uylings CG Van Eden JPC De Bruin MGP Feenstra CMA Pennartz Progress in brain research 2000 Elsevier Science London
67. DD Dougherty, AP Weiss, GR Cosgrove Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression J Neurosurg 99 2003 1010 1017
68. G Okada, Y Okamoto, S Morinobu, S Yamawaki, N Yokota Attenuated left prefrontal activation during a verbal fluency task in patients with depression Neuropsychobiology 47 2003 21 26
69. EJ Rose, E Simonotto, KP Ebmeier Limbic over-activity in depression during preserved performance on the n-back task Neuroimage 29 2006 203 215
70. JB Pochon, R Levy, P Fossati The neural system that bridges reward and cognition in humans: an fMRI study Proc Natl Acad Sci USA 99 2002 5669 5674
71. WC Drevets, ME Raichle Reciprocal suppression of regional cerebral blood flow during emotional versus higher cognitive processes: implications for interactions between emotion and cognition Cogn Emotion 12 1998 353 385
72. V Kumari, MT Mitterschiffthaler, JD Teasdale Neural abnormalities during cognitive generation of affect in treatment-resistant depression Biol Psychiatry 54 2003 777 791
73. JA Gray, N McNaughton The neuropsychology of anxiety: an enquiry into the functions of the septo-hippocampal system 2nd edn. 2000 Oxford University Press Oxford
74. RG Heath Correlation of brain function with emotional behavior Biol Psychiatry 11 1976 463 480
75. R Elliott, JS Rubinsztein, BJ Sahakian, RJ Dolan The neural basis of mood-congruent processing biases in depression Arch Gen Psychiatry 59 2002 597 604
76. S Surguladze, MJ Brammer, P Keedwell A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder Biol Psychiatry 57 2005 201 209
77. GJ Siegle, SR Steinhauer, ME Thase, VA Stenger, CS Carter Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals Biol Psychiatry 51 2002 693 707
78. JD Steele, M Meyer, KP Ebmeier Neural predictive error signal correlates with depressive illness severity in a game paradigm Neuroimage 23 2004 269 280
79. JD Steele Depressive illness and emotional learning Curr Med Imaging Rev 1 2005 157 176
80. P Luu, P Collins, DM Tucker Mood, personality, and self-monitoring: negative affect and emotionality in relation to frontal lobe mechanisms of error monitoring J Exp Psychol Gen 129 2000 43 60
81. CB Holroyd, S Nieuwenhuis, RB Mars, MG Coles Anterior cingulate cortex, selection for action, and error processing MI Posner Cognitive neuroscience of attention 2004 Guildford Press London
82. CB Holroyd, S Nieuwenhuis, N Yeung Dorsal anterior cingulate cortex shows fMRI response to internal and external error signals Nat Neurosci 7 2004 497 578
83. P Luu, DM Tucker, D Derryberry, M Reed, C Poulsen Electrophysiological responses to errors and feedback in the process of action regulation Psychol Sci 14 2003 47 53
84. P Luu, SM Pederson The anterior cingulate cortex, regulating actions in context MI Posner Cognitive neuroscience of attention 2004 Guildford Press London
85. G Hajcak, N McDonald, RF Simons Anxiety and error-related brain activity Biol Psychol 64 2003 77 90
86. CB Holroyd, N Yeung Alcohol and error processing Trends Neurosci 26 2003 402 404
87. WJ Gehring, J Himle, LG Nisenson Action-monitoring dysfunction in obsessive-compulsive disorder Psychol Sci 11 2000 1 6
88. M Ruchsow, B Herrnberger, C Wiesend, G Gron, M Spitzer, M Kiefer The effect of erroneous responses on response monitoring in patients with major depressive disorder: a study with event-related potentials Psychophysiology 41 2004 833 840
89. M Ruchsow, B Herrnberger, P Beschoner, G Gron, M Spitzer, M Kiefer Error processing in major depressive disorder: evidence from event-related potentials J Psychiatr Res 2005 published online May 6. DOI:10.1016/j.jpsychires.2005.02. 002
90. CB Holroyd, MG Coles The neural basis of human error processing: reinforcement learning, dopamine, and the error-related negativity Psychol Rev 109 2002 679 709
91. ND Daw, S Kakade, P Dayan Opponent interactions between serotonin and dopamine Neural Netw 15 2002 603 616
92. DC Owens, PJ McKenna, R Davenport Clinical assessment: interviewing and examination EC Johnstone DC Owens SM Lawrie M Sharpe CPL Freeman Companion to psychiatric studies 2004 Churchill Livingstone Edinburgh
93. AT Beck, AJ Rush, BF Shaw, G Emery Cognitive therapy of depression: a treatment manual 1979 Guilford Press New York
94. J Scott Cognitive therapy for depression Br Med Bull 57 2001 101 113
95. ME Thase, ES Friedman, SR Berman Is cognitive behavior therapy just a 'nonspecific' intervention for depression? A retrospective comparison of consecutive cohorts treated with cognitive behavior therapy or supportive counseling and pill placebo J Affect Disord 57 2000 63 71
96. V Gloaguen, J Cottraux, M Cucherat, IM Blackburn A meta-analysis of the effects of cognitive therapy in depressed patients J Affect Disord 49 1998 59 72
97. M King, B Sibbald, E Ward Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care Health Technol Assess 4 2000 01 83
98. RH Perlis, AA Nierenberg, JE Alpert Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder J Clin Psychopharmacol 22 2002 474 480
99. ME Thase, ES Friedman, AL Fasiczka Treatment of men with major depression: a comparison of sequential cohorts treated with either cognitive-behavioral therapy or newer generation antidepressants J Clin Psychiatry 61 2000 466 472
100. F de Jonghe, M Hendricksen, G van Aalst Psychotherapy alone and combined with pharmacotherapy in the treatment of depression Br J Psychiatry 185 2004 37 45
101. ES Paykel, J Scott, JD Teasdale Prevention of relapse in residual depression by cognitive therapy: a controlled trial Arch Gen Psychiatry 56 1999 829 835
102. JD Teasdale, ZV Segal, JM Williams, VA Ridgeway, JM Soulsby, MA Lau Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy J Consult Clin Psychol 68 2000 615 623
103. ES Paykel, J Scott, PL Cornwall Duration of relapse prevention after cognitive therapy in residual depression: follow-up of controlled trial Psychol Med 35 2005 59 68
104. PL Hensley, D Nadiga, EH Uhlenhuth Long-term effectiveness of cognitive therapy in major depressive disorder Depress Anxiety 20 2004 1 7
105. GL Klerman, NM Weismann, BJ Rounsaville, ES Chevron Interpersonal psychotherapy of depression 1984 Basic Books New York
106. M Barkham, GE Hardy Counselling and interpersonal therapies for depression: towards securing an evidence-base Br Med Bull 57 2001 115 132
107. NICE Depression: management of depression in primary and secondary care. Clinical Guideline 23 2004 National Institute for Clinical Excellence London
108. E Frank, VJ Grochocinski, CA Spanier Interpersonal psychotherapy and antidepressant medication: evaluation of a sequential treatment strategy in women with recurrent major depression J Clin Psychiatry 61 2000 51 57
109. G Browne, M Steiner, J Roberts Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs J Affect Disord 68 2002 317 330
110. E Frank, ME Thase Natural history and preventative treatment of recurrent mood disorders Annu Rev Med 50 1999 453 468
111. CF Reynolds 3rd, E Frank, JM Perel Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years JAMA 281 1999 39 45
112. AM Nezu Problem solving and behavior therapy revisited Behaviour Therapy 35 2004 1 33
113. AM Nezu, CM Nezu Problem solving therapy J Psychother Integr 11 2001 187 205
114. TJ D'Zurilla, MR Goldfried Problem solving and behavior modification J Abnorm Psychol 78 1 1971 107 126
115. TJ D'Zurilla, EC Chang, EJ Nottingham 4th, L Faccini Social problem-solving deficits and hopelessness, depression, and suicidal risk in college students and psychiatric inpatients J Clin Psychol 54 1998 1091 1107
116. LM Mynors-Wallis, DH Gath, A Day, F Baker Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care BMJ 320 2000 26 30
117. C Dowrick, G Dunn, JL Ayuso-Mateos Problem solving treatment and group psychoeducation for depression: multicentre randomised controlled trial. Outcomes of Depression International Network (ODIN) Group BMJ 321 2000 1450 1454
118. JE Barrett, JW Williams Jr, TE Oxman Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years J Fam Pract 50 2001 405 412
119. E Frank, P Rucci, W Katon Correlates of remission in primary care patients treated for minor depression Gen Hosp Psychiatry 24 2002 12 19
120. BE Wampold, T Minami, TW Baskin, S Callen Tierney A meta-(re)analysis of the effects of cognitive therapy versus 'other therapies' for depression J Affect Disord 68 2002 159 165
121. APA Practice guideline for the treatment of patients with major depressive disorder 2nd edn. 2000 American Psychiatric Association Arlington, VA
122. DJ Nutt Death and dependence: current controversies over the selective serotonin reuptake inhibitors J Psychopharmacol 17 2003 355 364
123. MT Walsh, TG Dinan Selective serotonin reuptake inhibitors and violence: a review of the available evidence Acta Psychiatr Scand 104 2001 84 91
124. A Herxheimer, B Mintzes Antidepressants and adverse effects in young patients: uncovering the evidence CMAJ 170 2004 487 489
125. Committee on Energy and Commerce FDA's role in protecting the public health: examining FDA's review of safety and efficacy concerns in anti-depressant use by children. Hearing before the subcommittee on oversight and investigations of the committee on energy and commerce 2004 House of Representatives, One Hundred Eighth Congress, Second Session Washington, DC
126. IVD Weller, D Ashby, R Brook Report of the Committee on Safety of Medicines expert working group on the safety of selective serotonin reuptake inhibitor antidepressants 2004 Medicines and Healthcare products Regulatory Agency London
127. F Davidoff, CD DeAngelis, JM Drazen Sponsorship, authorship, and accountability Lancet 358 2001 854 856
128. GA Fava Conflict of interest in psychopharmacology: can Dr Jekyll still control Mr Hyde? Psychother Psychosom 73 2004 1 4
129. CJ Whittington, T Kendall, P Fonagy, D Cottrell, A Cotgrove, E Boddington Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data Lancet 363 2004 1341 1345
130. T Wohlfarth, F Lekkerkerker, B van Zwieten Use of selective serotonin reuptake inhibitors in childhood depression Lancet 364 2004 659 660
131. RD Gibbons, K Hur, DK Bhaumik, JJ Mann The relationship between antidepressant medication use and rate of suicide Arch Gen Psychiatry 62 2005 165 172
132. MF Grunebaum, SP Ellis, S Li, MA Oquendo, JJ Mann Antidepressants and suicide risk in the United States, 1985-1999 J Clin Psychiatry 65 2004 1456 1462
133. D Gunnell, J Saperia, D Ashby Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review BMJ 330 2005 385
134. D Fergusson, S Doucette, KC Glass Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials BMJ 330 2005 396
135. H Jick, JA Kaye, SS Jick Antidepressants and the risk of suicidal behaviours JAMA 292 2004 338 343
136. C Martinez, S Rietbrock, L Wise Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study BMJ 330 2005 389
137. G Isacsson, P Holmgren, J Ahlner Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14,857 suicides Acta Psychiatr Scand 111 2005 286 290
138. BI Yerevanian, RJ Koek, JD Feusner, S Hwang, J Mintz Antidepressants and suicidal behaviour in unipolar depression Acta Psychiatr Scand 110 2004 452 458
139. EJ Sanz, C De-las-Cuevas, A Kiuru, A Bate, R Edwards Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis Lancet 365 2005 482 487
140. T Burt, SH Lisanby, HA Sackeim Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis Int J Neuropsychopharmacol 5 2002 73 103
141. A Pascual-Leone, B Rubio, F Pallardo, MD Catala Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression Lancet 348 1996 233 237
142. MS George, EM Wassermann, TA Kimbrell Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial Am J Psychiatry 154 1997 1752 1756
143. DH Avery, K Claypoole, L Robinson Repetitive transcranial magnetic stimulation in the treatment of medication-resistant depression: preliminary data J Nerv Ment Dis 18 1999 114 117
144. TA Kimbrell, JT Little, RT Dunn Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism Biol Psychiatry 46 1999 1603 1613
145. E Klein, I Kreinin, A Chistyakov Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study Arch Gen Psychiatry 56 1999 315 320
146. C Loo, P Mitchell, P Sachdev, B McDarmont, G Parker, S Gandevia Double-blind controlled investigation of transcranial magnetic stimulation for the treatment of resistant major depression Am J Psychiatry 156 1999 946 948
147. F Padberg, P Zwanzger, H Thoma Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS Psychiatry Res 88 1999 163 171
148. N Stikhina, EB Lyskov, MP Lomarev, ZA Aleksanian, VO Mikhailov, SV Medvedev [Transcranial magnetic stimulation in neurotic depression] Zh Nevrol Psikhiatr Im S S Korsakova 99 1999 26 29
149. RM Berman, M Narasimhan, G Sanacora A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression Biol Psychiatry 47 2000 332 337
150. GW Eschweiler, C Wegerer, W Schlotter Left prefrontal activation predicts therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) in major depression Psychiatry Res 99 2000 161 172
151. MS George, Z Nahas, M Molloy A controlled trial of daily left prefrontal cortex TMS for treating depression Biol Psychiatry 48 2000 962 970
152. M Garcia-Toro, A Pascual-Leone, M Romera Prefrontal repetitive transcranial magnetic stimulation as add on treatment in depression J Neurol Neurosurg Psychiatry 71 2001 546 548
153. SH Lisanby, A Pascual-Leone, SM Sampson, LS Boylan, T Burt, HA Sackeim Augmentation of sertraline antidepressant treatment with transcranial magnetic stimulation Biol Psychiatry 49 2001 81S 81S
154. F Manes, R Jorge, M Morcuende, T Yamada, S Paradiso, RG Robinson A controlled study of repetitive transcranial magnetic stimulation as a treatment of depression in the elderly Int Psychogeriatr 13 2001 225 231
155. NN Boutros, R Gueorguieva, RE Hoffman, DA Oren, A Feingold, RM Berman Lack of a therapeutic effect of a 2-week sub-threshold transcranial magnetic stimulation course for treatment-resistant depression Psychiatry Res 113 2002 245 254
156. F Padberg, P Zwanzger, ME Keck Repetitive transcranial magnetic stimulation (rTMS) in major depression: relation between efficacy and stimulation intensity Neuropsychopharmacology 27 2002 638 645
157. CK Loo, PB Mitchell, VM Croker Double-blind controlled investigation of bilateral prefrontal transcranial magnetic stimulation for the treatment of resistant major depression Psychol Med 33 2003 33 40
158. Z Nahas, FA Kozel, X Li, B Anderson, MS George Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy Bipolar Disord 5 2003 40 47
159. U Herwig, Y Lampe, FD Juengling Add-on rTMS for treatment of depression: a pilot study using stereotaxic coil-navigation according to PET data J Psychiatr Res 37 2003 267 275
160. J Hoeppner, M Schulz, G Irmisch, R Mau, D Schlafke, J Richter Antidepressant efficacy of two different rTMS procedures. High frequency over left versus low frequency over right prefrontal cortex compared with sham stimulation Eur Arch Psychiatry Clin Neurosci 253 2003 103 109
161. PB Fitzgerald, TL Brown, NA Marston, ZJ Daskalakis, A De Castella, J Kulkarni Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial Arch Gen Psychiatry 60 2003 1002 1008
162. A Hausmann, G Kemmler, M Walpoth No benefit derived from repetitive transcranial magnetic stimulation in depression: a prospective, single centre, randomised, double blind, sham controlled "add on" trial J Neurol Neurosurg Psychiatry 75 2004 320 402
163. RE Jorge, RG Robinson, A Tateno Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study Biol Psychiatry 55 2004 398 405
164. PE Holtzheimer 3rd, J Russo, KH Claypoole, P Roy-Byrne, DH Avery Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation Depress Anxiety 19 2004 24 30
165. CD Kauffmann, MA Cheema, BE Miller Slow right prefrontal transcranial magnetic stimulation as a treatment for medication-resistant depression: a double-blind, placebo-controlled study Depress Anxiety 19 2004 59 62
166. UP Mosimann, W Schmitt, BD Greenberg Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients Psychiatry Res 126 2004 123 133
167. E Poulet, J Brunelin, C Boeuve Repetitive transcranial magnetic stimulation does not potentiate antidepressant treatment Eur Psychiatry 19 2004 382 383
168. F Koerselman, DM Laman, H van Duijn, MA van Duijn, MA Willems A 3-month, follow-up, randomized, placebo-controlled study of repetitive transcranial magnetic stimulation in depression J Clin Psychiatry 65 2004 1323 1328
169. WP Dunlap, JM Cortina, JB Vaslow, MJ Burke Meta-analysis of experiments with matched groups or repeated measures designs Psychol Methods 1 1996 170 177
170. PM Shajahan, MF Glabus, JD Steele Left dorso-lateral repetitive transcranial magnetic stimulation affects cortical excitability and functional connectivity, but does not impair cognition in major depression Prog Neuropsychopharmacol Biol Psychiatry 26 2002 945 954
171. AP Strafella, T Paus, M Fraraccio, A Dagher Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex Brain 126 2003 2609 2615
172. ME Keck, T Welt, MB Muller Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system Neuropharmacology 43 2002 101 109
173. W Paulus Toward establishing a therapeutic window for rTMS by theta burst stimulation Neuron 45 2005 181 183
174. YZ Huang, MJ Edwards, E Rounis, KP Bhatia, JC Rothwell Theta burst stimulation of the human motor cortex Neuron 45 2005 201 206
175. EM Wassermann Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the safety of repetitive transcranial magnetic stimulation, June 5-7, 1996 Electroencephalogr Clin Neurophysiol 108 1998 1 16
176. SH Lisanby, B Luber, TE Schlaepfer, HA Sackeim Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy Neuropsychopharmacology 28 2003 1852 1865
177. AJ Dwork, V Arango, M Underwood Absence of histological lesions in primate models of ECT and magnetic seizure therapy Am J Psychiatry 161 2004 576 578
178. M Kosel, C Frick, SH Lisanby, HU Fisch, TE Schlaepfer Magnetic seizure therapy improves mood in refractory major depression Neuropsychopharmacology 28 2003 2045 2048
179. SH Lisanby, T Moscrip, O Morales, B Luber, C Schroeder, HA Sackeim Neurophysiological characterization of magnetic seizure therapy (MST) in non-human primates Suppl Clin Neurophysiol 56 2003 81 99
180. UK ECT Review Group Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis Lancet 361 2003 799 808
181. NICE Technology appraisal guidance 59: electroconvulsive teatment. technology appraisal guidances 2003 National Institute for Clinical Excellence London
182. SH Lisanby, JH Maddox, J Prudic, DP Devanand, HA Sackeim The effects of electroconvulsive therapy on memory of autobiographical and public events Arch Gen Psychiatry 57 2000 581 590
183. RM Greenberg, CH Kellner Electroconvulsive therapy: a selected review Am J Geriatr Psychiatry 13 2005 268 281
184. HA Sackeim, RF Haskett, BH Mulsant Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial JAMA 285 2001 1299 1307
185. DA Groves, VJ Brown Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects Neurosci Biobehav Rev 29 2005 493 500
186. HS Mayberg, AM Lozano, V Voon Deep brain stimulation for treatment-resistant depression Neuron 45 2005 651 660
187. CRAG Working Group Neurosurgery for mental disorder (J2318 7/96) 1996 HM Stationery Office Scotland Edinburgh
188. B Nuttin, P Cosyns, H Demeulemeester, J Gybels, B Meyerson Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder Lancet 354 1999 1526
189. V Sturm, D Lenartz, A Koulousakis The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders J Chem Neuroanat 26 2003 293 339
190. R Newcombe The lesion in stereotactic subcaudate tractotomy Br J Psychiatry 126 1975 478 481
191. DL Sackett, WS Richardson, W Rosenberg, RB Haynes Evidence-based medicine: how to practice and teach EBM 1998 Churchill Livingstone London
192. K Matthews, MS Eljamel Status of neurosurgery for mental disorder in Scotland. Selective literature review and overview of current clinical activity Br J Psychiatry 182 2003 404 411
193. ML Kringelbach, ET Rolls The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology Prog Neurobiol 72 2004 341 372
194. AR Damasio Descarte's error: emotion, reason and the human brain 1994 Papermac London
195. KV Baev, KA Greene, FF Marciano Physiology and pathophysiology of cortico-basal ganglia-thalamocortical loops: theoretical and practical aspects Prog Neuropsychopharmacol Biol Psychiatry 26 2002 771 804